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Although NK cells are considered part of the innate immune system, a series of evidences has demonstrated that they possess
characteristics typical of the adaptive immune system. These NK adaptive features, in particular their memory-like functions, are
discussed from an ontogenetic and evolutionary point of view.
1. Introduction
Innate immunity and adaptive immunity are two comple-
mentary aspects of the immune response, which consists of a
complex system of interactions aimed either at the clearance
of pathogens or at the elimination of transformed cells.
Although the two terms, inherited from the biology of the last
century, present themselves as antithetical, the high degree
of cooperation and interdependence between immunological
mechanisms makes a clear-cut distinction between the two
concepts increasingly difficult. This difficulty is also caused
by the fact that, from a phylogenetic point of view, the
adaptive immunity can be considered an evolution and an
improvement of the innate immunity, and the coexistence
of partially similar and mutually intertwined mechanisms is
therefore possible [1].
The lymphoid cells which are traditionally considered
as the effectors of innate immunity are NKT cells and the
so-called ILC (innate lymphoid cells), among which NK
cells are one of the most important populations [2]. They
recognize their ligands in a non-MHC restricted way and,
as part of the innate immunity, are generally considered
unable to remember antigens and to increase the magnitude
of their response over time [3]. The lymphoid cells which are
traditionally considered as the effectors of adaptive immunity
are T and B lymphocytes. They feature both the need to
recognize the antigen and the ability to arouse a faster and
stronger response when they encounter their cognate antigen
for a second time. The two mechanisms underlying this last
function, which is called immunologic memory, are basically
the same in both populations.The first consists of an antigen-
dependent clonal proliferation, and the second of a capability
to maintain for a very long time (sometimes throughout life)
a population of derived cells able to proliferate again on the
occasion of a further encounter with the same antigen.
In T cells the process of memory formation can be
divided into 3 distinct phases [4]. Initially there is a phase
of “expansion” during which clones of naive T cells expand
and differentiate into effector T cells following exposure to
foreign antigens in the framework of the major histocom-
patibility system (MHC); this is followed by a phase called
“contraction,” during which most effector T cells undergo
apoptosis. Only a few cells survive and enter the third stage,
called “memory,” during which they tend to persist and self-
renew, ready to encounter the same antigen to which they
had been previously exposed [5]. The receptor that plays a
key role in the activation of the transcriptional program of
naive T cells towards the formation of memory T cells is the
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Figure 1: NK cell subsets. The majority of peripheral blood human NK cells belongs to the highly cytotoxic CD56dim/CD16bright NK subset,
while the “cytokine producers” CD56bright NK cells are more abundant in secondary lymphoid tissues. Some differences in the receptor
expression and response to stimuli are indicated; remarkably, the level of CD16 expression has functional consequences for the antibody-
dependent cell cytotoxic (ADCC) mechanism.
T cell receptor or TCR [6], whose rearrangement during the
maturation in the thymus allows recognition of any virtually
possible antigenic determinant.
Gene rearrangement and the establishment of a memory
cell population are features which are shared by B lympho-
cytes, whose antigen receptor (BCR) consists in membrane-
bound immunoglobulins. After the first encounter with the
antigen, B lymphocytes proliferate as well, giving rise to
expanded populations of cells sharing the same antigen
receptor. Compared to T lymphocytes, B lymphocytes are
characterized by the presence of further mechanisms aimed
at improving the efficacy of the response. The first mecha-
nism is called somatic hyper mutation process (SHM) and
consists in a modulation of the antigen receptor affinity by
inserting random point mutations in the sequences coding
for the variable regions of the receptorial immunoglobulin.
Such editing, which takes place in the germinal center, is
followed by the positive selection of the cells which display
an improved antigen recognition [7].The secondmechanism,
also carried out in the germinal center, is called isotype-
switching or class-switch recombination (CSR). According
to CSR, postgerminative B cells and related plasma cells
mount and produce immunoglobulins characterized by a
new constant region. When secreted, these isotype-switched
immunoglobulins are able to perform different biological
activities, aimed at amore rapid clearance of pathogens in the
different contexts in which they are released [7]. Irrespective
of the different strategies put in place to ensure the presence
of long-lived populations, or to improve their response,
there is no doubt that the effectiveness of the immunologic
answer relies on the gene rearrangement able to amplify the
repertoire of receptors.
It is interesting to note that the amplitude of the rear-
rangement depending repertoire is not the same in every cell
population able to rearrange. It is similar in B and alpha/ beta
T lymphocytes, but it appears significantly reduced in gam-
ma/delta T lymphocytes, which are considered as a phyloge-
netically older population [1], specialized in the immediate
recognition of a reduced range of pathogens [8]. From this
point of view, gamma/delta T lymphocytes, as well as NKT
cells, which are traditionally included in the innate immunity
mainly because their effector activity is independent ofMHC,
are actually located in an overlapped gray area between innate
and adaptive immunity [9]. They further differ from other
effectors characterized by the expression of receptors not
subjected to rearrangement processes. NK cells belong to this
latter group.
2. Natural Killer Cells: Part of
Innate Immunity
Natural Killer (NK) cells were initially described for their
functional ability to kill cancer cells without prior sensitiza-
tion. For this feature, they have been always counted within
the innate immunity. They represent 10–15% of circulating
lymphocytes which are able not only to lyse tumor and
pathogen-infected cells, but also to secrete cytokines.NK cells
respond to both cytokine stimulation and cell to cell contacts
with fast kinetics, resulting in strong effectors when B and T
cells, which recognize specifically foreign antigens, are still in
limited number or absent.
Human NK cells are a heterogeneous population of
cytotoxic cells that can be divided into two main subsets,
based on the different density of expression of CD16 and
CD56: CD56dim/CD16bright andCD56bright/CD16dim/neg [10].
Both NK populations can mediate cytotoxicity and secrete
cytokines, but, similar to CD8 and CD4 T cells, they have
significant phenotypic and functional differences (Figure 1).
CD56dim/CD16bright NK cells represent about 90% of NK
cells in peripheral blood, and they show a low expression of
CD56 and a high expression ofCD16 and the humankiller cell
immunoglobulin- (Ig-) like receptors (KIRs); functionally
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they perform strong antibody-dependent cell cytotoxicity
(ADCC) and spontaneous cytotoxic activity, preferentially
against cells of hematopoietic origin. CD56bright NK cells
show a high expression of CD56 andCD94/NKG2A antigens;
functionally they have a high ability to produce immunoreg-
ulatory cytokines, in particular interferon- (IFN-) 𝛾 and
tumor necrosis factor- (TNF-) 𝛼. CD56bright and CD56dim
NK cells have been proposed to represent either different NK
cell stages or distinct NK subpopulations [10–12]. Consistent
with this latter hypothesis are the evidences of their different
pathways of in vitro differentiation [12–14] and responses
to stimuli. In fact, CD56bright and CD56dim NK cells are
preferentially activated by NK activating cytokines or by cell
targets, respectively [15, 16].
It is known that NK cells develop, in both mice and
humans, in the bone marrow. Nevertheless, NK cell progeni-
tors can be also found in secondary lymphoid and peripheral
organs, suggesting that they can leave bone marrow and
differentiate in other locations [17–19]. NK cell maturation
is accompanied by the expression of a number of activating
and inhibitory receptors in a fashion that prevents NK-
mediated autoaggression against normal cells [20]. Indeed,
inhibitory and activating receptors finely tune NK cell
functional activities. Among several inhibitory receptors
expressed by NK cells, those sensitive to MHC class I
(MHC-I) molecules expressed on target cells are of particular
interest. From an evolutionary point of view, the lectin-like
CD94/NKG2(A,B) heterodimeric receptors are the oldest;
in fact they are expressed on both human and mouse NK
cells. These receptors bind to human HLA-E or mouse Qa-
1, whose expression on the cell surface depends on loaded
peptides deriving from MHC-I molecules [21]. By a phylo-
genetic point of view, the lectin-like Ly49 receptor family
in mice and the human killer cell immunoglobulin- (Ig-)
like receptor (KIR) family are more recent. In fact, despite
their similar function of recognizing MHC-I molecules, they
have different structures, suggesting that the genes evolved
after the divergence of the two species. These receptors sense
overallMHC-I expression on target cells and eventually block
activating signals; intriguingly, activating forms of KIRs,
Ly49, and lectin-like CD94/NKG2(C,E,H) have been also
described [20, 21]. The MHC-I sensing receptors transmit
inhibitory signals which spare normal self-cells, but on the
other hand they allow increasing the cytotoxic potential of
NK cells that express them, forming the molecular basis of
the “missing self” recognition [22]. As a matter of fact, the
MHC-I-specific inhibitory receptors regulate not only NK
cell reactivity against targets, but also their overall “licence”
to kill target cells in a missing self-MHC-I fashion [23, 24].
Of note, some allele of KIR-HLA-I pairs seems to protect
from HIV [25, 26], suggesting that KIRs, differently from
CD94/NKG2(A,B) receptors, could represent a new immune
armament against recently evolved diseases. Several receptors
have been described to participate in the spontaneous NK
cell activation, among which are NKp46, NKp30, and NKp44
(collectively termed Natural Cytotoxicity Receptors, NCRs),
NKG2D, DNAM-1 (CD226), 2B4 (CD244), LFA-1 (CD11a-
CD18), and CD2 [27]. Some of these act as costimulatory
receptors that synergize with the real triggering receptors.
The most important activating receptors responsible for NK
spontaneous cytotoxicity are NCRs and NKG2D, which, by
engaging their ligands expressed on the surface of “stressed”
cells in the absence of inhibitory signals, lead to NK cell acti-
vation and target cell death [20, 28]. Another important acti-
vating receptor is represented by CD16 (or Fc𝛾RIIIA), the low
affinity receptor for immunoglobulin G (IgG), able to bind
immune complexes and IgG-coated, opsonized cells. Binding
of this receptor with the crystallisable fragment of IgG on the
opsonized target cells activates CD56dim/CD16bright NK cells
to kill through ADCC mechanism and to produce cytokines
(see Figure 1).
Interestingly, NK cells play a complementary role to CTLs
in MHC-I-driven immune responses: MHC-I molecules
loaded with peptides are necessary to activate T cells, while
they inhibit NK cells (Figure 2(a)). Of note, missing self-
recognition of NK cells can be exploited in the improvement
of haploidentical hematopoietic stem cell transplantation
[29–32]. In fact, a haploidentical donor (usually a relative),
who expresses the class I groups which are missing in the
recipient, mediates NK cell killing of recipient leukemic,
dendritic, and T cells (alloreaction) which reduces leukemic
relapse, graft versus host disease (GvHD), and graft rejection
(Figure 2(b)).
3. First Evidences of NK Adaptive Features
Although NK cells are considered innate immune cells, the
fact that NK cells possess a number of characteristics in
common with the cells of the adaptive immune system is
emerging. NK cells share, in particular with T cells, not only
the common lymphoid and the bipotent T/NK progenitors
[33, 34], but also a series of functional features. In fact, NK
cells have been described to be activated by dendritic cells
[35], involved in autoimmune response [36], and able to
recognize and respond to viral peptides [37, 38]. In particular,
it has been shown that someMHC-I loaded viral peptides can
antagonize inhibitory signals from KIRs, possibly masking
KIR-mediated self-recognition.This last observation suggests
that, in analogy to the T cell thymic maturation, a selection
of KIR-HLA-I pairs able to “recognize” self-antigens should
sometime occur during ontogenesis or phylogenesis. Evi-
dences that some combinations of maternal KIR and fetal
HLA-I molecules influence the reproductive success [39]
suggest the possibility that, along the evolution of the human
species, maternal uterine KIR+NKcells could have biased the
HLA-I (loaded with fetal peptides) of newborn. Of note, the
too low- or too high-affinity binding ofmaternal KIRs to fetal
MHC class I molecules is related to the birth of babies too
small or too large, who are less likely to survive, a process
resembling the outcome of thymic selection dependent on
binding affinity of TCR for self-peptide-MHC complexes
[40, 41].
Finally, NK subpopulations are stably expanded in
response to some viral infections or cancers and seem to
be involved in the long lasting control of these diseases
[25, 26, 42–44]. Altogether, these findings have highlighted
that NK cells possess adaptive features and have suggested
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Figure 2: (a)MHCclass I-drivenmechanisms of recognition byNK andT cells. T lymphocytes andNK cells display complementary reactions
in response toMHC-I surface expression on target cells. MHC-I loaded with (foreign) peptides are necessary to bind to T cell receptor (TCR)
and to activate T cells. On the contrary, the engagement of HLA-I molecules with NK MHC-I sensing inhibitory receptors (KIR and/or
CD94/NKG2A) blocks NK cell responses. When NK activating receptors (NKG2D and/or NCRs) recognize their ligands on surface of target
cells that lack MHC-I molecules (self-MHC-I missing recognition), NK cells kill, releasing granzymes and perforins. (b) Exploitation of NK
cell missing self-recognition in the improvement of haploidentical hematopoietic stem cell transplantation. Hematopoietic stem cells (HSC)
from a selected donor can generate alloreactive CD56dim NK cells which are able to kill not only the patient’s neoplastic cells, but also patient
dendritic cells (DCs) and T lymphocytes, reducing leukemic relapse, graft versus host disease (GvHD), and graft rejection.
their memory-like activity. This last characteristic has been
observed for the first time in a mouse model of hapten-
induced contact hypersensitivity (CHS) [45]. In Rag2-
deficient mice, lacking both B and T cells, NK cells are
necessary and sufficient to mediate contact hypersensitivity
and hapten-induced memory [46] (Figure 3(a)). Although
the molecular basis for the specificity remains unclear, NK
cell-mediated CHS is strictly antigen-specific, since different
haptens used for restimulation did not produce a memory-
like response [47]. Adoptive NK cell transfer from donor
liver, but not from other donor’s districts, is itself capable
of transferring memory to a naive recipient, suggesting that
memory-like NK cells are localized in the liver [46, 47].
These memory-like NK cells are characterized by expression
of CXCR6 chemokine receptor, and the need of its presence
on NK cell surface for mediating CHS has suggested a
role in their liver homing and the importance of their
liver localization [47]. Indeed, during the priming phase,
only liver-resident CD49a+/DX5− NK cells proliferate and
confer hapten-specific CHS memory response [48], while
liver CD49a−/DX5+ conventional NK cells have been shown
to promote CTL anti-HBV activity via IFN-𝛾 secretion, likely
induced by dendritic cell- (DC-) derived IL-12 [49]. Surpris-
ingly, during the effector phase of memory, CD49a−/DX5+
NK cells increased both in the liver and at the site of
second exposure. This observation raised the possibility that
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Figure 3: Memory-like NK cell formation. (a) Antigen-dependent memory-like NK cells. During CMV infection, NK cell memory is
generated. In mouse it occurs through the recognition of MCMVm157 protein by the activating Ly49H receptor, while in human the ligand
involved has not been identified yet; nevertheless, HCMV infection is associated with the expansion of CD94/NKG2C+ NK cell population.
Hapten-specific memory-like NK cells are generated in the liver of a mousemodel of hapten-induced contact hypersensitivity (CHS). Among
the hepatic NK cell populations, CD49a+/DX5− NK cells confer hapten-specific CHSmemory-like responses, while the expression of CXCR6
is believed to have a role in their liver homing. (b) Antigen-independent long-lived cytokine-activated NK cells. They are generated after
exposure to cytokines (IL-12, IL-15, and IL-18) and are characterized by prolonged longevity, CD25 expression, and intense IFN-𝛾 production
upon restimulation. (c) Hepatic localization of memory-like NK cells in CHS model. (1a) NK cells are activated in draining lymph nodes
by antigen presenting cells, and newly generated memory-like NK cells move into the liver. Alternatively, (1b) antigenic recognition by NK
cells directly occurs in the liver. (2) Second exposure to the hapten activates CD49a+/DX5− memory-like NK cells and (3) migration of
CD49a−/DX5+ NK cells into organs where the hapten is present.
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liver-resident CD49a+/DX5− NK cells may change their phe-
notype into CD49a−/DX5+ NK cells or alternatively theymay
directly or indirectly induce proliferation of CD49a−/DX5+
NK cells [48].
Exogenous substances introduced into the body from
outside through gastrointestinal absorption are first trans-
ported by the bloodstream to liver, which senses and metab-
olizes the absorbed nutrients and chemical molecules. In the
liver, hepatic immune cells directly participate in the control
and elimination of potentially dangerous biological and
chemical material [50]; thus, it is possible that the antigenic
activation of NK cells occurs directly in that organ [48, 51].
Indeed, bacterial products, toxins, and nutritional antigens
have to be quickly eliminated by innate immune cells, before
these dangerous substances could create damage at systemic
level [50]. Alternatively, NK cells could be activated in
draining lymph nodes by antigen presenting cells, homing
thereafter in the liver. After a second antigen exposure, these
hepatic memory NK cells would move from the liver to
the organ where the second exposure has taken place [52]
(Figure 3(c)).
4. Memory-Like NK Cells in Viral Infections
The role of NK cells in the control of viral infections in
humans has been highlighted in some rare genetic diseases
resulting from a deficiency of NK cell number. In particular,
human natural killer cell deficiencies have been associated
with an increased susceptibility to herpesvirus infections
[53]. Interestingly, the first evidence of an antigen-specific
memory-like NK cell response in viral infections has been
reported in a murine cytomegalovirus (MCMV) model [54].
The m157 glycoprotein, specifically expressed by MCMV-
infected cells, is recognized by the Ly49H activating receptor
expressed on a murine NK cell subset [38, 55] and is able
to induce a selective activation and expansion of Ly49H+
NK cell subset [56]. However, to fully activate NK cells,
antigen receptor engagement synergizes with inflammatory
cytokines. Similar to activated T cells, these effector NK
cells undergo a contraction phase, during which they con-
stitute a pool of long-lived, self-renewing antigen-specific
cells (Figure 3(a)). Following a subsequent exposure to
MCMV, specific memory NK cells respond more quickly
and effectively than the naive NK cells [54]. Similarly
to MCMV, human cytomegalovirus (HCMV) is able to
induce the expansion of a NK subpopulation expressing the
CD94/NKG2C activating receptor [57, 58]. The expansion of
CD94/NKG2C+ NK cells is believed to be linked to the recog-
nition of a ligand on HCMV infected cells [59], but unlike
in the mouse, this ligand has not been identified yet (Fig-
ure 3(a)). Surprisingly, this CD56dim/CD16bright/NKG2C+
cell subset does not perform a specific cytotoxicity against
fibroblasts infected with HCMV, as expected from memory
cells. Nevertheless, when stimulated by opsonized HCMV+
target cells via CD16 receptor, CD56dim/CD16bright/NKG2C+
cells display an enhanced ability to proliferate [60] and to
secrete cytokines (in particular TNF-alpha) [59, 61]. Notably,
humans lacking one KLRC2 allele that encodes NKG2C
receptor had a compromised NK cell differentiation during
HCMV infection, with altered adaptive response and high
anti-HCMV IgG titers [62, 63]. Goodier and colleagues [63]
concluded that the impairment of HCMV control by adaptive
NK cells would need a higher B cell response. On the other
hand, since anti-HCMV IgG-coated infected cells are able to
preferentially activate adaptiveNK cells, it is also possible that
CD56dim/CD16bright/NKG2C+ functional adaptations may
be “aimed” to improve the cooperation with B lymphocytes,
finally leading to a lower need of anti-HCMV IgG secretion
for controlling HCMV.
Increase of CD56dim/CD16bright/NKG2C+ NK cells has
also been found in patients with other viral infections, such
as hepatitis C virus (HCV), hepatitis B virus (HBV) [64, 65],
EBV (Epstein Barr Virus) [66], or HIV-1 [67], but only in
people previously infected with HCMV as well, suggesting
that expansion of the CD94/NKG2C+ NK cell subset is
CMV specific rather than a generalized response after virus
infection. Interestingly, HCMV drives clonal-like expansions
of NK cell subsets commonly characterized by increased
expression not only of NKG2C, but also of self-HLA-I-
specific KIRs and CD57, as well as decreased expression
of Fc𝜀R𝛾, SYK, and EAT-2 adaptor molecules, which may
drive the functional changes of these adaptive, memory-like
NK cells [19, 60, 68, 69]. Indeed, HCMV induces epigenetic
modification of signaling molecules in adaptive NK cells that
affect their effector function [60].
Moreover, NK cells with memory characteristics have
been found after exposure to viral-like particles or in various
viral infections such as genital herpes (HSV-2), vaccinia
virus, influenza, and human immunodeficiency virus type 1
(HIV-1) [47, 70–73]. A murine study has demonstrated the
existence of short-term antigen-specific NK memory against
HSV-2 virus. Following the reexposure to the same viral
antigen, memory-like NK cells are able to respond with an
increased IFN-𝛾 production [70]; nevertheless they do not
acquire NKG2C antigen expression [71], confirming again
the peculiar association of CD94/NKG2C+ subset with CMV
infection. Finally, poxvirus infection has also been described
to induce an immunological NKmemory response inmouse.
A subset (Thy1+) of NK cells, generated in a first exposure
to infection, are sufficient to provide protection against lethal
doses of virus injections and, similarly to CHS model, reside
in liver [72]. Differently from vaccinia virus- and CHS-
inducedmemory-likeNK cells, after influenza virus infection
the primary site of proliferation of long-lived NK cells is
the bone marrow [73]. Since influenza-induced long-lived
NK cells proliferate even after respiratory syncytial virus
challenge, the authors conclude that cytokine activation alone
is likely generating these long-livedNKcells and that the bone
marrow is not only a site of NK differentiation but also an
important site for homing of memory-like NK cells [73].
Although in the majority of these viral infection mod-
els NK cells are thought to protect host in an antigen-
specific manner, the NK cell proliferative signals produced
by proinflammatory cytokines IL-18, type I-IFN, and in
particular IL-12 are also indispensable in the generation
of virus-specific NK cell memory [74, 75]. Downstream of
inflammatory signals, Zbtb32 transcription factor has been
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shown to have an essential cell-intrinsic function to generate
NK cell memory [76]. Intriguingly, it has been also described
that a subset of NK cells transiently expressed RAG during
their development and its expression is critical for their
survival following virus infection, indicating a cell-intrinsic
role for RAG inNK cells.This subset ofNK cells is responsible
for more robust memory response to MCMV infection [77],
suggesting an involvement of RAG during the development
of a NK cell subset specialized in the generation of MCMV-
specific memory-like NK cells.
5. Antigen-Independent Long-Lived
Cytokine-Activated NK Cells: Involvement
in Trained Immunity and Vaccine
Numerous experimental evidences suggest that the stimu-
lation of NK cells with proinflammatory cytokines is able
to generate long-lived activated NK cells. Such NK cells
activated in vitro with IL-12, IL-15, and IL-18 and then
inoculated in Rag1−/− mice produce higher amount of IFN-𝛾
after a subsequent restimulation with cytokines. This feature
ismaintained for at least 12 weeks after inoculation and seems
to be an intrinsic characteristic of the cytokine-activated NK
cells that can be transmitted to the progeny [78, 79]. Similar
cytokine-induced memory-like NK cells were also observed
in both human CD56dim and CD56bright NK cell subsets [80].
The increased capacity to produce IFN-𝛾 and the prolonged
longevity of these long-term activated NK cells induced by
proinflammatory cytokines seem to be independent of the
recognition of a viral antigen by activating receptors. There-
fore, these cytokine-induced long-lived activated NK cells
show an antigen-independent functional memory, which
is distinct from that induced by CMV specific activating
receptors (Figure 3(b)).
Nevertheless, similar to HCMV-induced CD94/NKG2C+
NK cells and memory type 1 T helper cells [60, 81], an
exposure of human NK cells to IL-12, IL-15, and IL-18
resulted in NK cell stable demethylation of the IFNG locus
regulatory regions [81], suggesting that epigenetic imprinting
is a common hallmark driving both antigen-dependent and
antigen-independent memory-like NK cells.
Both CD56dim and CD56bright NK cell subsets, preac-
tivated with IL-12, IL-15, and IL-18, showed an increased
production of IFN-𝛾 (but not degranulation) to a subsequent
stimulation with cytokines or with the HLA-I-negative K562
leukemic cell line [80], suggesting new potential approaches
in NK cell-based immunotherapies against cancer. A charac-
teristic of thesememory-like cells is the prolonged expression
of CD25, which confers responsiveness to low amounts of IL-
2 [82], thus indirectly enhancing NK cell response to IL-2
produced by CD4+ T cells.These observations have provided
the rationale for the immunotherapeutic strategies based
on adoptive cell transfer of cytokine preactivated NK cells,
followed by low dose IL-2 administration. Remarkably, in
somepatientswith acutemyeloid leukemia, clinical responses
after adoptive transfer of long-lived cytokine-activated cells
have been described [83]. In a recent study it has also
been shown that, after annual flu vaccination, NK cells
were more prone to produce IFN-𝛾 and also to provide
a response against other influenza strains different from the
vaccine, ensuring a wider coverage and a vaccine-induced
cross-protection for several months [84]. This response is
reminiscent of the phenomenon termed “trained immunity,”
first described inmonocytes. According to this phenomenon,
monocytes respond with an increased cytokine production
upon restimulation due to epigenetic changes induced by the
first stimulation or priming [85, 86]. Similar to long-lived
cytokine-activated NK cells, the improved responsiveness
to subsequent challenges coincided with their epigenetic
changes and was independent of the nature of restimulation.
As a matter of fact, this kind of response has also been
described in NK cells. Interestingly, in mice lacking B and
T cells, priming of NK cells with Bacillus Calmette-Gue´rin
(BCG) gave protection against a wide spectrum of pathogens
[87]. In line with these observations is the employment of
BCG as adjuvant in cancer therapy [88]. Indeed, BCG has
been shown to induce in vivo antitumor effects via DC toll-
like receptor 2 (TLR2) and TLR4 [89] and proinflammatory
cytokines produced by DC in response to TLRs likely rep-
resent the explanation of anticancer mechanisms induced by
microbial components [28].
Interestingly, NK cells appear to play a role in the control
of rabies virus infection after vaccination. As a matter of fact,
after in vitro PBMC stimulation with inactivated rabies virus,
only NK cells in vaccinated individuals showed a strong and
prolonged cytokine (IFN-𝛾) production and degranulation
[90]. NK cells represent the main population of cells able to
secrete IFN-𝛾 and to degranulate in the first 12–18 hours after
reexposure to the inactivated virus, indicating that they are
necessary for a rapid response after vaccination. During the
first exposure to the virus, the interaction of the virus with
antigen presenting cells (APC)would induce IL-12, IL-18, and
also IL-15 secretion which would prime not only naı¨ve T, but
alsoNK cells into long-lived CD25+ NK cells [82]. During the
reexposure of the virus, the intense NK cytokine production
and the potent NK degranulation would be also determined
by the synergy of proinflammatory cytokines from APC with
IL-2 from antigen-specific CD4+ T cells (Figure 4).
Similarly, it has been shown that the response of T cells
induced by a HIV-1 specific vaccine is able to improve NK
cell function, typically impaired in individuals with HIV-1
chronic infection [91]. However, vaccination against specific
viral antigens (influenza, vesicular stomatitis virus, or HIV-1)
has been shown to generate not only long-lived cytokine-
activated NK cells but also memory-like NK cells capable
of protecting mice against viral challenge in a virus/antigen-
specific manner [47]. The data indicate that NK cells are
important actors in vaccine-induced immune responses and
assessment of NK cell activation after vaccination could rep-
resent a further and important indicator of vaccine efficacy.
6. Concluding Remarks and Future Research
NK cells, as well as monocytes, have historically been consid-
ered short-lived, rapid, and aspecific effectors of the innate
immunity; however, it is now clear that, once sensitized by
viral antigens or haptens, they are also able to mount an
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adaptive response that resembles the classical immunological
memory [75]. In fact, challenging the classical concept of
immunological memory, NK cells with an extended lifespan
and an enhanced recall response have been characterized. NK
cells can respond to antigens although with a limited choice
of antigen specificity. The specific interaction between the
glycoprotein m157 and Ly49H receptor makes the MCMV
infection model a special case for the NK cell memory. This
NK antigen recognition resembles that of T cell memory
generation, since Ly49H+ memory-like NK cells require
costimulatory signals. In fact, Ly49H+ NK cells missing the
DNAM-1 receptor fail to expand and to form long-lived
memory NK cells [92].
6.1. Cooperation of NK Cells with B Cells. Differently from
mice, in humans it is not clear whether the expansion of
CD56dim/CD16bright/NKG2C+ NK cells is aimed at pro-
tecting against a second exposure to the virus or rather
represents a “side effect” of HCMV infection. Of note,
CD56dim/CD16bright/NKG2C+ NK cells develop a specific
adaptive feature [59–61] characterized by an enhanced
response via CD16 stimulation, which suggests an improved
cooperation ofmemory-likeNK cells with B cells. In line with
this hypothesis, the T cell cytokine IL-21 has been described
to induce both the development of CD56dim/CD16bright NK
cells from CD34+ hematopoietic progenitors [12, 13, 93] and
the switching of Ig produced by B cell to IgG1 and IgG3
isotypes [94], for which Fc𝛾RIIIA receptor (CD16 of NK
cells) displays a higher affinity [95]. Thus, through IL-21
secretion, T cells would be able to coordinate an ADCC
response, inducing both an adequate isotype switching in B
cells and anADCCspecializedNKcell subset. Similarly, other
T cell cytokines (i.e., IL-2 and/or type 2) might be involved
in the generation of memory-like NK cells with a peculiar
understanding with B cells.
6.2. Sites of Memory NK Cell Generation and Homing.
Although there are several evidences of human NK antigen
recognition and generation of memory-like NK cells, many
gaps remain in understanding the mechanisms, particularly
the sites and the receptors involved in these processes. Both
HCMV and MCMV memory-like NK cells are not organ-
specific, while in CHS model and in some viral infection
memory-like NK cells are resident in the liver [46–48, 51, 72].
For this reason, it has been suggested that in CHS model the
antigen recognition by NK cells could occur in the liver [48,
51]. On the other hand, the bone marrow is the primary site
of long-livedNK cells generated after influenza infection [73].
The homing of memory-like NK cells might be imprinted by
the first site of NK antigen/hapten recognition, consequently
depending on the NK cell subset involved, on the way of
entering into the body, and on the organ for which the
antigen/hapten expresses its tropism.
6.3. Are NK-LGLs Memory-Like NK Cells? How human NK
cells could recognize antigens is under debate. A possibility is
suggested by the observation that viral peptides can interfere
with MHC-I recognition by NK inhibitory receptors [37],
unleashing NK cell response in a “masking self-recognition”
fashion. On the other hand, activating NK cell receptors
that selectively recognize viral peptides/antigensmounted on
MHC-I or HLA-E have been associated to NK memory-like
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and NK-LGL expansion [54, 57, 96]. Intriguingly, HCMV-
driven CD94/NKG2C+ NK clonal expansion shows several
similarities with NK-type chronic lymphoproliferative dis-
ease of granular lymphocytes (LGL). NK-LGL is an indolent
NK cell disease characterized by a persistent increase of
circulating NK cells, typically expressing activating forms
of KIRs [97]. Remarkably, in the large majority of NK-LGL
patients, there is a serologic evidence of past viral infection,
suggesting that viral infection and collateral proinflammatory
cytokine secretion may play a role early in disease patho-
genesis [97, 98]. Intriguingly, NK-LGL positive for KIR3DS1
are mainly confined to HLA-Bw4 positive individuals [99,
Zambello R, unpublished data], suggesting that KIR3DS1+
clonal expansionmight be driven by (viral) peptidesmounted
on HLA-Bw4 molecules. Therefore, the NK-LGL could be
a good “model” to explore in order to shed more light
to NK clonal expansion. Moreover, a heavy methylation of
inhibitory KIR3DL1 promoter was also described in NK-LGL
[100]. The authors conclude that the lack of the inhibitory
signal together with the increased expression of activating
receptors could play a role in the disease pathogenesis.
On the other hand, epigenetic modifications are typical of
both adaptive memory T and memory NK cells and have
been described in both virus-specific and cytokine-induced
memory-like NK cells [60, 75, 81]. Thus, a more detailed
understanding of the epigenetic control could help to better
understand the mechanisms of chronic lymphoproliferative
diseases and lead to new NK cell-based immunotherapeutic
approaches.
6.4. Are TLRs Involved in NK Memory Formation? Of note,
the limited antigen specificity of activating Ly49H (and
likely CD94-NKG2C) receptors against pathogen ligands is
not so far from that of TLRs, an old and evolutionarily
conserved system for recognition of pathogen-associated
molecules and danger-associated molecular patterns [89].
Similar to Ly49H and CD94-NKG2C receptors, these innate
antigen-specific receptors require the presence of accessory
cells or of proinflammatory cytokines to induce NK cell
responses [101]. Moreover, resembling NK cell response to
cytokines [15, 16], there are evidences of heterogeneity in
the ability to respond to TLRs [102], further confirming that
NK cell subsetting is an intrinsic characteristic of NK cell
lineage. Whether or not TLRs are involved in NK memory-
like formation is not documented and evidences for innate
immune memory (basically, trained immunity) associated
with TLRs are limited [75]. Nevertheless, distinct TLRs have
been associated with a specific protection against several
viral infections [101], raising the possibility that some virus-
specific memory-like NK cells could be driven by a specific
TLR engagement. Indeed, TLR2 signaling on NK cells, but
not on accessory cells, has been shown to be necessary for
efficient NK cell activation and control of vaccinia virus
infection in vivo [103]. Moreover, a report has highlighted a
prominent role of TLRs in contact allergen-induced innate
immune activation [104]. The authors describe a hapten-
specific CHS selectively mediated by TLR2 or TLR4 [104].
These evidences are suggestive of a role of TLRs in the
hapten-specificmemory-likeNK cell-generation. If this is the
case, the hapten-specific NK cell response should be directly
mediated by NK TLRs rather than DC ones. In fact, TLR-
activated DCs would, in turn, produce a general hapten-non-
specific inflammation.
From an evolutionary point of view, TLRs are the pro-
totypes of the antigen specific receptors. It is tempting to
speculate that the main difference between the two types
of activating receptors lies in the MHC-I “intermediation.”
NK cells are known to be the first lymphoid cells to appear
during ontogenesis andphylogenesis andTLRs one of the first
activating receptors expressed during NK cell “evolution.”
Activating receptors recognizing MHC-I molecules/peptides
evolved later, together or after the occurrence of MHC-I
molecules either on an ancient NK cell population or on a
new evolved NK subset.
6.5. Heterogeneity of the NK Cell Population. Whether
memory-like NK cells can develop from all or only a
subset of NK cells is currently not clear. However, several
observations suggest the possibility that different NK cell
subsets act against distinct pathogens or in a different
manner. This is attested by the recent evidence that mouse
Ly49H+ and Ly49H− NK cell subsets give a complemen-
tary protection to MCMV differentiating into memory-
like and cytokine-activated NK cells, respectively [105]. A
similar behavior has been reported both for mouse liver
CD49a+/DX5− and CD49a−/DX5+ and for human peripheral
blood CD56dim/CD16bright and CD56bright/CD16dim/neg NK
cell subsets. In line with this, there is also the observation
that RAG expression during NK cell ontogeny correlates with
functionally distinct progeny cells, indicating heterogeneity
in the NK cell population (see review [19]), as, in general, in
ILC groups. Remarkably, there are recent evidences of innate
lymphoid cell redundancy [106]. It is possible that during
the evolution of the immune system some ILC subsets, orig-
inally developed against a specific pathogen, have lost their
usefulness in the current (relatively “aseptic”) environment
(“hic et nunc”). Nevertheless, the immune system and life in
general maintain trace of their existence; they do not forget
the past, their history, perhaps becausememory is an intrinsic
characteristic of the immune system and, in general, of the
current life, likely selected among the primordial types of
life. This could suggest that they are not eliminated during
evolution because might they become useful again in the
future?
6.6. Walking Four Paths along Ontogenetic Memory Lane.
Altogether the data would suggest that while B and T cell
are preferentially able to mount an immunological response
inducing modification within a relatively homogeneous pop-
ulation (differing mainly for the conformation of one recep-
tor), NK cells and in general ILCs along their ontogeny
have privileged the expansion of different cell populations
with distinct functional features. We suggest that this NK
cell heterogeneity constitutes also the basis of the different
types of NK cell memories. Based on NK cell receptors
and/or subsets involved in NK memory-like formation, a
sequence of four different types of NK cell memory occurring
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during NK cell evolution could be hypothesized: (1) long-
lived cytokine-activated NK cells (low specificity, possibly
limited to specific cytokine-responder NK cell subsets); (2)
TLR-mediated memory-like NK cells (perhaps against some
viral antigens and haptens); (3) CD94/NKG2C-mediated
memory-like NK cells (specific against HCMV); (4) acti-
vating Ly49-mediated memory-like NK cells and activating
KIR-mediated (NK-LGL) memory-like NK cells (specificity
against MCMV and perhaps some viral infections, resp.)
(Figure 5). A similar sequence of NK cell types could be
also imagined for NK cell-mediated autoimmune diseases,
in which some activating KIRs have been associated with
an increased susceptibility [36, 107]. In this case, instead of
foreign, self-antigens or peptides (mounted or not mounted
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on MHC-I) are supposed to drive an anomalous recognition
by activating KIRs and perhaps TLRs expressed by NK cell
subsets (Figure 5).
6.7. Do NK Cells Protect the Species from New Evolved
Pathogens? Interestingly, in some subjects, depending on the
type of disease and on the relationships between KIRs and
their ligands, NK cells can function as well as CTLs, pro-
ducing a long-lasting immune cell response against specific
viral infections, neoplastic transformation, and autoimmune
disorders.These evidences suggest a possible complementary
and nonredundant role shared by T and NK cell populations
(and ILCs in general), the first preferentially aimed to protect
single members of a species from “known” pathogens and
the second, thanks to their interindividual heterogeneity,
preferentially aimed to protect the species as a whole from
new evolved pathogens. It is well known that in the single
individual NK cells rapidly tackle and predispose to the
development of following immune-adaptive eradication of
“known” pathogens. It is tempting to speculate that similarly,
in the occurrence of new pathogens evolved under the
strong selective pressure produced by the immune (adaptive)
system, within the whole population the interindividual
heterogeneity of NK cells gives more chance to temporarily
protect the species (allowing reaching the reproductive age),
finally giving the time to develop a new specialized and
stronger adaptive immunity, which will become heritage
of the following generations. The majority of the scientific
studies that evaluate the performance of the different immune
populations are performed in the current relatively “static”
environment and do not take in account this evolutionary
scenario. For this reason, the actual impact and importance
of this heterogeneous population of cells has been for a
long time underestimated. On the other hand, in a more
“dynamic” and challenging environment, as in the case in
which a population faces an infectious agent never met
before, the impact of NK cell response has been suggested to
increase [25, 26, 108].
6.8. Conclusive Considerations. The rapidity of NK cell
response could be exploited to exert an early control of
infections, and in case of HIV, which target cells of the
adaptive immune system, it could be finalized to prematurely
limit the spread of the virus. The fact that NK cells acquire a
“memory” broad spectrum, able to act also against pathogens
or transformed cells not involved in the first activation, has
opened new horizons in the development of next-generation
vaccines and in therapeutic use of long-lived activated NK
cells against cancer. Further studies are required to elucidate
the mechanisms involved in the generation and maintenance
of the memory-cell pools, to identify the specific markers
expressed by these memory NK subsets, and to understand
the pathways involved in antigen recognition, not to speak of
the molecular epigenetic mechanisms behind the generation
of memory-like NK cells.
Competing Interests
The authors have no conflicting financial interests to declare.
Acknowledgments
The authors would like to thank Dr. Renato Zambello for
NK-LGL data, Professors Andrea Cossarizza and Andrea
Fattorossi for suggestions, and Dr. Federico Bastianelli and
Silvio Cecchini for their technical assistance. Loris Zamai,
who has thought and written most of the “NK part” of the
manuscript, is grateful to Dr. Bice Perussia for introducing
him into the complex and fascinating field of NK cell biology
and his father, who both prematurely passed away.
References
[1] G. W. Litman, J. P. Cannon, and L. J. Dishaw, “Reconstruct-
ing immune phylogeny: new perspectives,” Nature Reviews
Immunology, vol. 5, no. 11, pp. 866–879, 2005.
[2] M. D. Hazenberg and H. Spits, “Human innate lymphoid cells,”
Blood, vol. 124, no. 5, pp. 700–709, 2014.
[3] L. L. Lanier, “Shades of grey-the blurring view of innate and
adaptive immunity,” Nature Reviews Immunology, vol. 13, no. 2,
pp. 73–74, 2013.
[4] M. A. Williams and M. J. Bevan, “Effector and memory CTL
differentiation,” Annual Review of Immunology, vol. 25, pp. 171–
192, 2007.
[5] C. J. Luckey, D. Bhattacharya, A. W. Goldrath, I. L. Weissman,
C. Benoist, and D. Mathis, “Memory T and memory B cells
share a transcriptional program of self-renewal with long-term
hematopoietic stem cells,” Proceedings of the National Academy
of Sciences of the United States of America, vol. 103, no. 9, pp.
3304–3309, 2006.
[6] X.Wang,M. B. F.Werneck, B. G.Wilson et al., “TCR-dependent
transformation of mature memory phenotype T cells in mice,”
Journal of Clinical Investigation, vol. 121, no. 10, pp. 3834–3845,
2011.
[7] J. K. Hwang, F. W. Alt, and L.-S. Yeap, “Related mechanisms of
antibody somatic hypermutation and class switch recombina-
tion,” Microbiology Spectrum, vol. 3, no. 1, Article ID MDNA3-
0037-2014, 2015.
[8] M. Kronenberg, “When less is more: T lymphocyte populations
with restricted antigen receptor diversity,” Journal of Immunol-
ogy, vol. 193, no. 3, pp. 975–976, 2014.
[9] W. Holtmeier and D. Kabelitz, “𝛾𝛿 T cells link innate and adap-
tive immune responses,”Chemical Immunology and Allergy, vol.
86, pp. 151–183, 2005.
[10] M. A. Cooper, T. A. Fehniger, andM. A. Caligiuri, “The biology
of human natural killer-cell subsets,”Trends in Immunology, vol.
22, no. 11, pp. 633–640, 2001.
[11] A. G. Freud and M. A. Caligiuri, “Human natural killer cell
development,” Immunological Reviews, vol. 214, no. 1, pp. 56–72,
2006.
[12] L. Zamai, G. Del Zotto, F. Buccella et al., “Cytotoxic functions
and susceptibility to apoptosis of human CD56bright NK cells
differentiated in vitro from CD34+ hematopoietic progenitors,”
Cytometry Part A, vol. 81, no. 4, pp. 294–302, 2012.
[13] J. Parrish-Novak, S. R. Dillon, A. Nelson et al., “Interleukin
21 and its receptor are involved in NK cell expansion and
regulation of lymphocyte function,” Nature, vol. 408, no. 6808,
pp. 57–63, 2000.
12 Journal of Immunology Research
[14] L. Zamai, L. Galeotti, G. Del Zotto, B. Canonico, P. Miran-
dola, and S. Papa, “Identification of a NCR+/NKG2D+/LFA-
1(low)/CD94(-) immature humanNK cell subset,”Cytometry A,
vol. 75, no. 11, pp. 893–901, 2009.
[15] C. Fauriat, E. O. Long, H.-G. Ljunggren, and Y. T. Bryceson,
“Regulation of human NK-cell cytokine and chemokine pro-
duction by target cell recognition,” Blood, vol. 115, no. 11, pp.
2167–2176, 2010.
[16] A.DeMaria, F. Bozzano, C. Cantoni, and L.Moretta, “Revisiting
human natural killer cell subset function revealed cytolytic
CD56dimCD16+ NK cells as rapid producers of abundant IFN-
𝛾 on activation,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 108, no. 2, pp. 728–732, 2011.
[17] A. G. Freud, B. Becknell, S. Roychowdhury et al., “A human
CD34(+) subset resides in lymph nodes and differentiates into
CD56bright natural killer cells,” Immunity, vol. 22, no. 3, pp.
295–304, 2005.
[18] P. Vacca, C. Vitale, E. Montaldo et al., “CD34+ hematopoietic
precursors are present in human decidua and differentiate
into natural killer cells upon interaction with stromal cells,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 108, no. 6, pp. 2402–2407, 2011.
[19] N. K. Bjo¨rkstro¨m, H. Ljunggren, and J.Michae¨lsson, “Emerging
insights into natural killer cells in human peripheral tissues,”
Nature Reviews Immunology, vol. 16, no. 5, pp. 310–320, 2016.
[20] A. Moretta, C. Bottino, M. Vitale et al., “Activating receptors
and coreceptors involved in human natural killer cell-mediated
cytolysis,” Annual Review of Immunology, vol. 19, pp. 197–223,
2001.
[21] V. M. Braud, D. S. J. Allan, C. A. O’Callaghan et al., “HLA-E
binds to natural killer cell receptors CD94/NKG2A, B and C,”
Nature, vol. 391, no. 6669, pp. 795–799, 1998.
[22] H. G. Ljunggren and K. Karre, “In search of the ‘missing self ’:
MHC molecules and NK cell recognition,” Immunology Today,
vol. 11, pp. 237–244, 1990.
[23] S. Kim, J. Poursine-Laurent, S. M. Truscott et al., “Licensing
of natural killer cells by host major histocompatibility complex
class I molecules,” Nature, vol. 436, no. 7051, pp. 709–713, 2005.
[24] N. Anfossi, P. Andre´, S. Guia et al., “Human NK Cell Education
by Inhibitory Receptors forMHCClass I,” Immunity, vol. 25, no.
2, pp. 331–342, 2006.
[25] M. P. Martin, X. Gao, J.-H. Lee et al., “Epistatic interaction
between KIR3DS1 and HLA-B delays the progression to AIDS,”
Nature Genetics, vol. 31, no. 4, pp. 429–434, 2002.
[26] M. P. Martin, Y. Qi, X. Gao et al., “Innate partnership of HLA-B
and KIR3DL1 subtypes against HIV-1,” Nature Genetics, vol. 39,
no. 6, pp. 733–740, 2007.
[27] Y. T. Bryceson, M. E. March, H.-G. Ljunggren, and E. O. Long,
“Activation, coactivation, and costimulation of resting human
natural killer cells,” Immunological Reviews, vol. 214, no. 1, pp.
73–91, 2006.
[28] L. Zamai, C. Ponti, P. Mirandola et al., “NK cells and cancer,”
The Journal of Immunology, vol. 178, no. 7, pp. 4011–4016, 2007.
[29] L. Ruggeri, M. Capanni, M. Casucci et al., “Role of natural killer
cell alloreactivity in HLA-mismatched hematopoietic stem cell
transplantation,” Blood, vol. 94, no. 1, pp. 333–339, 1999.
[30] D. Pende, S. Marcenaro, M. Falco et al., “Anti-leukemia activity
of alloreactive NK cells in KIR ligand-mismatched haploidenti-
calHSCT for pediatric patients: evaluation of the functional role
of activating KIR and redefinition of inhibitory KIR specificity,”
Blood, vol. 113, no. 13, pp. 3119–3129, 2009.
[31] A. Velardi, L. Ruggeri, A. Mancusi, F. Aversa, and F. T. Chris-
tiansen, “Natural killer cell allorecognition of missing self in
allogeneic hematopoietic transplantation: a tool for immun-
otherapy of leukemia,” Current Opinion in Immunology, vol. 21,
no. 5, pp. 525–530, 2009.
[32] A. Moretta, D. Pende, F. Locatelli, and L. Moretta, “Activating
and inhibitory killer immunoglobulin-like receptors (KIR) in
haploidentical haemopoietic stem cell transplantation to cure
high-risk leukaemias,” Clinical and Experimental Immunology,
vol. 157, no. 3, pp. 325–331, 2009.
[33] M. J. Sa´nchez, M. O. Muench, M. G. Roncarolo, L. L. Lanier,
and J. H. Phillips, “Identification of a common T/natural killer
cell progenitor in human fetal thymus,” Journal of Experimental
Medicine, vol. 180, no. 2, pp. 569–576, 1994.
[34] H. Spits, L. L. Lanier, and J. H. Phillips, “Development of human
T and natural killer cells,” Blood, vol. 85, no. 10, pp. 2654–2670,
1995.
[35] G. Ferlazzo and C. Mu¨nz, “NK cell compartments and their
activation by dendritic cells,” Journal of Immunology, vol. 172,
no. 3, pp. 1333–1339, 2004.
[36] G. W. Nelson, M. P. Martin, D. Gladman, J. Wade, J. Trowsdale,
and M. Carrington, “Cutting edge: Heterozygote advantage
in autoimmune disease: hierarchy of protection/susceptibility
conferred by HLA and killer Ig-like receptor combinations in
psoriatic arthritis,” Journal of Immunology, vol. 173, no. 7, pp.
4273–4276, 2004.
[37] L. Fadda, G. Borhis, P. Ahmed et al., “Peptide antagonism as a
mechanism for NK cell activation,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 107, no.
22, pp. 10160–10165, 2010.
[38] H. Arase, E. S. Mocarski, A. E. Campbell, A. B. Hill, and L.
L. Lanier, “Direct recognition of cytomegalovirus by activating
and inhibitory NK cell receptors,” Science, vol. 296, no. 5571, pp.
1323–1326, 2002.
[39] S. E. Hiby, J. J. Walker, K. M. O’Shaughnessy et al., “Com-
binations of maternal KIR and fetal HLA-C genes influence
the risk of preeclampsia and reproductive success,” Journal of
Experimental Medicine, vol. 200, no. 8, pp. 957–965, 2004.
[40] S. E. Hiby, R. Apps, O. Chazara et al., “Maternal KIR in com-
bination with paternal HLA-C2 regulate human birth weight,”
Journal of Immunology, vol. 192, no. 11, pp. 5069–5073, 2014.
[41] A. Moffett and F. Colucci, “Co-evolution of NK receptors and
HLA ligands in humans is driven by reproduction,” Immuno-
logical Reviews, vol. 267, no. 1, pp. 283–297, 2015.
[42] M. Lo´pez-Botet, A. Angulo, and M. Guma´, “Natural killer
cell receptors for major histocompatibility complex class I
and related molecules in cytomegalovirus infection,” Tissue
Antigens, vol. 63, no. 3, pp. 195–203, 2004.
[43] J. A. Campillo, J. A. Mart´ınez-Escribano, M. R. Moya-Quiles et
al., “Natural killer receptors on CD8 T cells and natural killer
cells from different HLA-C phenotypes in melanoma patients,”
Clinical Cancer Research, vol. 12, no. 16, pp. 4822–4831, 2006.
[44] G. Alter, S. Rihn, K. Walter et al., “HLA class I subtype-
dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells
during acute human immunodeficiency virus type 1 infection,”
Journal of Virology, vol. 83, no. 13, pp. 6798–6805, 2009.
[45] A. V. Gorbachev and R. L. Fairchild, “Induction and regulation
of T-cell priming for contact hypersensitivity,” Critical Reviews
in Immunology, vol. 21, no. 5, pp. 451–472, 2001.
[46] J. G. O’Leary, M. Goodarzi, D. L. Drayton, and U. H. von
Andrian, “T cell- and B cell-independent adaptive immunity
Journal of Immunology Research 13
mediated by natural killer cells,” Nature Immunology, vol. 7, no.
5, pp. 507–516, 2006.
[47] S. Paust, H. S. Gill, B.-Z. Wang et al., “Critical role for the
chemokine receptor CXCR6 in NK cell-mediated antigen-
specific memory of haptens and viruses,” Nature Immunology,
vol. 11, no. 12, pp. 1127–1135, 2010.
[48] H. Peng, X. Jiang, Y. Chen et al., “Liver-resident NK cells confer
adaptive immunity in skin-contact inflammation,” Journal of
Clinical Investigation, vol. 123, no. 4, pp. 1444–1456, 2013.
[49] M. Zheng, R. Sun, H. Wei, and Z. Tian, “NK cells help induce
Anti-Hepatitis B virus CD8+ T cell immunity in mice,” The
Journal of Immunology, vol. 196, no. 10, pp. 4122–4131, 2016.
[50] B. Gao, W.-I. Jeong, and Z. Tian, “Liver: an organ with
predominant innate immunity,” Hepatology, vol. 47, no. 2, pp.
729–736, 2008.
[51] X. Jiang, Y. Chen, H. Peng, and Z. Tian, “Memory NK cells: why
do they reside in the liver?”Cellular andMolecular Immunology,
vol. 10, no. 3, pp. 196–201, 2013.
[52] S. Paust and U. H. Von Andrian, “Natural killer cell memory,”
Nature Immunology, vol. 12, no. 6, pp. 500–508, 2011.
[53] J. S. Orange, “Human natural killer cell deficiencies and suscep-
tibility to infection,” Microbes and Infection, vol. 4, no. 15, pp.
1545–1558, 2002.
[54] J. C. Sun, J. N. Beilke, and L. L. Lanier, “Adaptive immune
features of natural killer cells,”Nature, vol. 457, no. 7233, pp. 557–
561, 2009.
[55] H. R. C. Smith, J. W. Heusel, I. K. Mehta et al., “Recognition of a
virus-encoded ligand by a natural killer cell activation receptor,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 99, no. 13, pp. 8826–8831, 2002.
[56] A. O. Dokun, S. Kim, H. R. C. Smith, H.-S. P. Kang, D. T.
Chu, and W. M. Yokoyama, “Specific and nonspecific NK cell
activation during virus infection,” Nature Immunology, vol. 2,
no. 10, pp. 951–956, 2001.
[57] M. Guma´, A. Angulo, C. Vilches, N. Go´mez-Lozano, N. Malats,
andM. Lo´pez-Botet, “Imprint of human cytomegalovirus infec-
tion on the NK cell receptor repertoire,” Blood, vol. 104, no. 12,
pp. 3664–3671, 2004.
[58] M. Della Chiesa, M. Falco, L. Muccio, A. Bertaina, F. Locatelli,
and A. Moretta, “Impact of HCMV infection on NK cell devel-
opment and function afterHSCT,” Frontiers in Immunology, vol.
4, article 458, 2013.
[59] A. Muntasell, A. Pupuleku, E. Cisneros et al., “Relationship
of NKG2C copy number with the distribution of distinct
cytomegalovirus-induced adaptiveNK cell subsets,”The Journal
of Immunology, vol. 196, no. 9, pp. 3818–3827, 2016.
[60] H. Schlums, F. Cichocki, B. Tesi et al., “Cytomegalovirus
infection drives adaptive epigenetic diversification of NK cells
with altered signaling and effector function,” Immunity, vol. 42,
no. 3, pp. 443–456, 2015.
[61] M. Costa-Garcia, A. Vera, M. Moraru, C. Vilches, M. Lo´pez-
Botet, and A. Muntasell, “Antibody- mediated response of
NKG2Cbright NK cells against human cytomegalovirus,” The
Journal of Immunology, vol. 194, pp. 2715–2724, 2015.
[62] A. Muntasell, M. Lo´pez-Montan˜e´s, A. Vera et al., “NKG2C
zygosity influences CD94/NKG2C receptor function and the
NK-cell compartment redistribution in response to human
cytomegalovirus,” European Journal of Immunology, vol. 43, no.
12, pp. 3268–3278, 2013.
[63] M. R. Goodier, M. J. White, A. Darboe et al., “Rapid NK
cell differentiation in a population with near-universal human
cytomegalovirus infection is attenuated by NKG2C deletions,”
Blood, vol. 124, no. 14, pp. 2213–2222, 2014.
[64] B. Oliviero, S. Varchetta, E. Paudice et al., “Natural killer
cell functional dichotomy in chronic hepatitis B and chronic
hepatitis C virus infections,”Gastroenterology, vol. 137, no. 3, pp.
1151–1160, 2009.
[65] V. Be´ziat, O. Dalgard, T. Asselah et al., “CMV drives clonal
expansion of NKG2C+ NK cells expressing self-specific KIRs
in chronic hepatitis patients,” European Journal of Immunology,
vol. 42, no. 2, pp. 447–457, 2012.
[66] D. W. Hendricks, H. H. Balfour Jr., S. K. Dunmire, D. O.
Schmeling, K. A. Hogquist, and L. L. Lanier, “Cutting edge:
NKG2ChiCD57+ NK cells respond specifically to acute infection
with cytomegalovirus and not epstein-barr virus,”The Journal of
Immunology, vol. 192, no. 10, pp. 4492–4496, 2014.
[67] A. de Maria and L. Moretta, “NK cell function in HIV-1
infection,” Current HIV Research, vol. 6, no. 5, pp. 433–440,
2008.
[68] S. Lopez-Verge`s, J. M. Milush, B. S. Schwartz et al., “Expansion
of a unique CD57+NKG2Cℎ𝑖 natural killer cell subset during
acute human cytomegalovirus infection,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 108, no. 36, pp. 14725–14732, 2011.
[69] B. Foley, S. Cooley, M. R. Verneris et al., “Human cytomega-
lovirus (CMV)-induced memory-like NKG2C+ NK cells are
transplantable and expand in vivo in response to recipient CMV
antigen,” Journal of Immunology, vol. 189, no. 10, pp. 5082–5088,
2012.
[70] M. F. Abdul-Careem, A. J. Lee, E. A. Pek et al., “Genital HSV-2
infection induces short-term NK cell memory,” PLoS ONE, vol.
7, no. 3, Article ID e32821, 2012.
[71] N. K. Bjo¨rkstro¨m, A. Svensson, K.-J. Malmberg, K. Eriksson,
and H.-G. Ljunggren, “Characterization of natural killer cell
phenotype and function during recurrent human HSV-2 infec-
tion,” PLoS ONE, vol. 6, no. 11, Article ID e27664, 2011.
[72] G. O. Gillard, M. Bivas-Benita, A.-H. Hovav et al., “Thy1+
NK cells from vaccinia virus-primed mice confer protection
against vaccinia virus challenge in the absence of adaptive
lymphocytes,” PLoS Pathogens, vol. 7, no. 8, Article ID e1002141,
2011.
[73] M. J. G. VanHelden, N. De Graaf, C. J. P. Boog, D. J. Topham, D.
M.W.Zaiss, andA. J. A.M. Sijts, “Thebonemarrow functions as
the central site of proliferation for long-lived NK cells,” Journal
of Immunology, vol. 189, no. 5, pp. 2333–2337, 2012.
[74] J. C. Sun, S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan,
and L. L. Lanier, “Proinflammatory cytokine signaling required
for the generation of natural killer cell memory,” Journal of
Experimental Medicine, vol. 209, no. 5, pp. 947–954, 2012.
[75] A. Cerwenka and L. L. Lanier, “Natural killer cell memory in
infection, inflammation and cancer,” Nature Reviews Immunol-
ogy, vol. 16, no. 2, pp. 112–123, 2016.
[76] A. M. Beaulieu, C. L. Zawislak, T. Nakayama, and J. C. Sun,
“The transcription factor Zbtb32 controls the proliferative burst
of virus-specific natural killer cells responding to infection,”
Nature Immunology, vol. 15, no. 6, pp. 546–553, 2014.
[77] J. M. Karo, D. G. Schatz, and J. C. Sun, “The RAG recombinase
dictates functional heterogeneity and cellular fitness in natural
killer cells,” Cell, vol. 159, no. 1, pp. 94–107, 2014.
[78] M. A. Cooper, J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero,
andW. M. Yokoyama, “Cytokine-induced memory-like natural
killer cells,” Proceedings of the National Academy of Sciences of
the United States of America, vol. 106, no. 6, pp. 1915–1919, 2009.
14 Journal of Immunology Research
[79] M. P. Keppel, L. Yang, and M. A. Cooper, “Murine NK cell
intrinsic cytokine-induced memory-like responses are main-
tained following homeostatic proliferation,” Journal of Immu-
nology, vol. 190, no. 9, pp. 4754–4762, 2013.
[80] R. Romee, S. E. Schneider, J. W. Leong et al., “Cytokine
activation induces human memory-like NK cells,” Blood, vol.
120, no. 24, pp. 4751–4760, 2012.
[81] M. Luetke-Eversloh, Q. Hammer, P. Durek et al., “Human
cytomegalovirus drives epigenetic imprinting of the IFNG locus
in NKG2Chi natural killer cells,” PLoS pathogens, vol. 10, no. 10,
Article ID e1004441, 2014.
[82] J.W. Leong, J. M. Chase, R. Romee et al., “Preactivation with IL-
12, IL-15, and IL-18 induces CD25 and a functional high-affinity
IL-2 receptor on human cytokine-inducedmemory-like natural
killer cells,” Biology of Blood and Marrow Transplantation, vol.
20, no. 4, pp. 463–473, 2014.
[83] R. Romee, M. Rosario, M. M. Berrien-Elliott et al., “Cytokine-
induced memory-like natural killer cells exhibit enhanced
responses against myeloid leukemia,” Science Translational
Medicine, vol. 8, no. 357, Article ID 357ra123, 2016.
[84] Y. Dou, B. Fu, R. Sun et al., “Influenza vaccine induces
intracellular immune memory of human NK cells,” PLoS ONE,
vol. 10, no. 3, Article ID e0121258, 2015.
[85] J. Kleinnijenhuis, J. Quintin, F. Preijers et al., “Bacille Calmette-
Gue´rin induces NOD2-dependent nonspecific protection from
reinfection via epigenetic reprogramming of monocytes,” Pro-
ceedings of the National Academy of Sciences of the United States
of America, vol. 109, no. 43, pp. 17537–17542, 2012.
[86] M. G. Netea, J. Quintin, and J. W. M. Van Der Meer, “Trained
immunity: a memory for innate host defense,” Cell Host and
Microbe, vol. 9, no. 5, pp. 355–361, 2011.
[87] J. Kleinnijenhuis, J. Quintin, F. Preijers et al., “BCG-induced
trained immunity in NK cells: role for non-specific protection
to infection,” Clinical Immunology, vol. 155, no. 2, pp. 213–219,
2014.
[88] R. Liu, F. Luo, X. Liu et al., “Biological response modifier in
cancer immunotherapy,” Advances in Experimental Medicine
and Biology, vol. 909, pp. 69–138, 2016.
[89] M.-F. Tsan, “Toll-like receptors, inflammation and cancer,”
Seminars in Cancer Biology, vol. 16, no. 1, pp. 32–37, 2006.
[90] A. Horowitz, R. H. Behrens, L. Okell, A. R. Fooks, and E. M.
Riley, “NK cells as effectors of acquired immune responses:
effector CD4+T cell-dependent activation ofNK cells following
vaccination,” Journal of Immunology, vol. 185, no. 5, pp. 2808–
2818, 2010.
[91] S. Jost, P. J. Tomezsko, K. Rands et al., “CD4+ T-cell help
enhances NK cell function following therapeutic HIV-1 vacci-
nation,” Journal of Virology, vol. 88, no. 15, pp. 8349–8354, 2014.
[92] T. Nabekura, M. Kanaya, A. Shibuya, G. Fu, N. R. J. Gascoigne,
and L. L. Lanier, “Costimulatory molecule DNAM-1 is essential
for optimal differentiation of memory natural killer cells during
mouse cytomegalovirus infection,” Immunity, vol. 40, no. 2, pp.
225–234, 2014.
[93] S. Sivori, C. Cantoni, S. Parolini et al., “IL-21 induces both rapid
maturation of human CD34+ cell precursors towards NK cells
and acquisition of surface killer Ig-like receptors,” European
Journal of Immunology, vol. 33, no. 12, pp. 3439–3447, 2003.
[94] J. Pe`ne, J.-F. Gauchat, S. Le´cart et al., “Cutting edge: IL-21 is a
switch factor for the production of IgG1 and IgG3 by human B
cells,”The Journal of Immunology, vol. 172, no. 9, pp. 5154–5157,
2004.
[95] P. Bruhns, B. Iannascoli, P. England et al., “Specificity and
affinity of human Fc𝛾 receptors and their polymorphic variants
for human IgG subclasses,” Blood, vol. 113, no. 16, pp. 3716–3725,
2009.
[96] R. Zambello, M. Falco, M. Della Chiesa et al., “Expression and
function of KIR and natural cytotoxicity receptors in NK-type
lymphoproliferative diseases of granular lymphocytes,” Blood,
vol. 102, no. 5, pp. 1797–1805, 2003.
[97] R. Zambello, A. Teramo, G. Barila`, C. Gattazzo, and G. Semen-
zato, “Activating KIRs in chronic lymphoproliferative disorder
of NK cells: protection from viruses and disease induction?”
Frontiers in Immunology, vol. 5, article 00072, 2014.
[98] R. Zambello, T. P. Loughran Jr., L. Trentin et al., “Serologic
and molecular evidence for a possible pathogenetic role of viral
infection in CD3-negative natural killer-type lymphoprolifera-
tive disease of granular lymphocytes,” Leukemia, vol. 9, no. 7, pp.
1207–1211, 1995.
[99] E. Scquizzato, A. Teramo, M. Miorin et al., “Genotypic evalua-
tion of killer immunoglobulin-like receptors in NK-type lym-
phoproliferative disease of granular lymphocytes,” Leukemia,
vol. 21, no. 5, pp. 1060–1069, 2007.
[100] C. Gattazzo, A. Teramo, M. Miorin et al., “Lack of expression
of inhibitory KIR3DL1 receptor in patients with natural killer
cell-type lymphoproliferative disease of granular lymphocytes,”
Haematologica, vol. 95, no. 10, pp. 1722–1729, 2010.
[101] M. Adib-Conquy, D. Scott-Algara, J.-M. Cavaillon, and F.
Souza-Fonseca-Guimaraes, “TLR-mediated activation of NK
cells and their role in bacterial/viral immune responses in
mammals,” Immunology and Cell Biology, vol. 92, no. 3, pp. 256–
262, 2014.
[102] S. Sivori, M. Falco, M. Della Chiesa et al., “CpG and double-
stranded RNA trigger human NK cells by toll-like receptors:
induction of cytokine release and cytotoxicity against tumors
and dendritic cells,” Proceedings of the National Academy of
Sciences of theUnited States of America, vol. 101, no. 27, pp. 10116–
10121, 2004.
[103] J. Martinez, X. Huang, and Y. Yang, “Direct TLR2 signaling
is critical for NK cell activation and function in response to
vaccinia viral infection,” PLoS Pathogens, vol. 6, no. 3, Article
ID e1000811, 2010.
[104] S. F. Martin, J. C. Dudda, E. Bachtanian et al., “Toll-like
receptor and IL-12 signaling control susceptibility to contact
hypersensitivity,” Journal of ExperimentalMedicine, vol. 205, no.
9, pp. 2151–2162, 2008.
[105] T. Nabekura and L. L. Lanier, “Tracking the fate of antigen-
specific versus cytokine-activated natural killer cells after cyto-
megalovirus infection,” The Journal of Experimental Medicine,
vol. 213, no. 12, pp. 2745–2758, 2016.
[106] F. Ve´ly, V. Barlogis, B. Vallentin et al., “Evidence of innate
lymphoid cell redundancy in humans,”Nature Immunology, vol.
17, no. 11, pp. 1291–1299, 2016.
[107] A. Poggi andM. R. Zocchi, “NK cell autoreactivity and autoim-
mune diseases,” Frontiers in Immunology, vol. 5, article 27, 2014.
[108] P. J. Norman, L. Abi-Rached, K. Gendzekhadze et al., “Unusual
selection on the KIR3DL1/S1 natural killer cell receptor in
Africans,” Nature Genetics, vol. 39, no. 9, pp. 1092–1099, 2007.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
